Revised forecast
Fiscal year ending March 2027 · Full yearPrevious forecast published 7 May 2026The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.
Net sales, business profit and profit for the period attributable to owners of the parent were revised following a review of economic conditions, sales conditions, raw material costs and initiatives in each business, including the impact of heightened tensions in the Middle East. In the Healthcare and Other segment, sales of electronic materials for high-performance substrates used in AI, servers and networks have remained strong.
| Item | Details |
|---|---|
| Net Sales | 1,723,000 million yen → 1,732,000 million yen（+0.5%） |
| Profit attributable to owners of the parent | 120,000 million yen → 123,500 million yen（+2.9%） |
| Net income per share | 126.16 yen → 129.84 yen |
| Fiscal Period Covered | Fiscal year ending March 2027 |
| Period Covered | Full year |
| Publication date of previous forecast | 7 May 2026 |
| Previous-period results | Net sales: ¥1,583,719 million; business profit: ¥181,163 million; profit for the period attributable to owners of the parent: ¥134,675 million; basic earnings per share: ¥138.36 |
| Reason for the revision | Net sales, business profit and profit for the period attributable to owners of the parent were revised following a review of economic conditions, sales conditions, raw material costs and initiatives in each business, including the impact of heightened tensions in the Middle East. In the Healthcare and Other segment, sales of electronic materials for high-performance substrates used in AI, servers and networks have remained strong. |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (4)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The revisions followed a review of economic conditions, sales conditions, raw material costs and initiatives in each business, including the impact of heightened tensions in the Middle East. In particular, the revisions reflected strong sales of electronic materials for high-performance substrates used in AI, servers and networks in the Healthcare and Other segment.